Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
124.15
+1.23 (1.00%)
At close: Mar 31, 2025, 4:00 PM
120.81
-3.34 (-2.69%)
Pre-market: Apr 1, 2025, 8:15 AM EDT

Jazz Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
2,4131,506881.48591.451,058
Upgrade
Short-Term Investments
580120--1,075
Upgrade
Trading Asset Securities
0.963.78---
Upgrade
Cash & Short-Term Investments
2,9941,630881.48591.452,133
Upgrade
Cash Growth
83.66%84.93%49.04%-72.27%97.97%
Upgrade
Receivables
716.77705.79651.49563.36396.49
Upgrade
Inventory
480.45597.04714.061,07395.4
Upgrade
Prepaid Expenses
177.41185.4891.91131.4162.42
Upgrade
Other Current Assets
260.58317.03267.19252.39152.49
Upgrade
Total Current Assets
4,6293,4352,6062,6112,840
Upgrade
Property, Plant & Equipment
227234.99301.38343.42257.1
Upgrade
Long-Term Investments
4.334.75.554.5
Upgrade
Goodwill
1,7161,7531,6931,828958.3
Upgrade
Other Intangible Assets
4,7565,4185,7947,1522,195
Upgrade
Long-Term Deferred Tax Assets
560.25477.83376.25311.1254.92
Upgrade
Long-Term Deferred Charges
9.496.489.2512.035.24
Upgrade
Other Long-Term Assets
110.1562.7649.6435.8121.22
Upgrade
Total Assets
12,01211,39310,83512,2996,536
Upgrade
Accounts Payable
77.87102.7590.76100.326.95
Upgrade
Accrued Expenses
821.98748.21757.86588.41315.16
Upgrade
Current Portion of Long-Term Debt
31604.953146.23249.16
Upgrade
Current Portion of Leases
14.7819.4515.9415.7614.46
Upgrade
Current Income Taxes Payable
18.7635.077.729.6125.2
Upgrade
Current Unearned Revenue
--0.462.092.55
Upgrade
Other Current Liabilities
74.1926.2629.4646.920.28
Upgrade
Total Current Liabilities
1,0391,537933.19809.3653.75
Upgrade
Long-Term Debt
6,0785,1115,6936,0191,849
Upgrade
Long-Term Leases
43.564.2677.0593.47140.04
Upgrade
Long-Term Unearned Revenue
---0.462.32
Upgrade
Long-Term Deferred Tax Liabilities
676.74847.71944.341,301130.4
Upgrade
Other Long-Term Liabilities
82.0596.3101.6110.73101.15
Upgrade
Total Liabilities
7,9197,6567,7508,3332,876
Upgrade
Common Stock
0.010.010.010.010.01
Upgrade
Additional Paid-In Capital
3,9143,7003,4773,5352,634
Upgrade
Retained Earnings
1,127878.66733.59830.231,160
Upgrade
Comprehensive Income & Other
-947.14-841.62-1,125-399.83-133.83
Upgrade
Total Common Equity
4,0943,7373,0863,9653,660
Upgrade
Shareholders' Equity
4,0943,7373,0863,9653,660
Upgrade
Total Liabilities & Equity
12,01211,39310,83512,2996,536
Upgrade
Total Debt
6,1675,8005,8176,1742,252
Upgrade
Net Cash (Debt)
-3,173-4,170-4,936-5,583-119.4
Upgrade
Net Cash Per Share
-48.07-57.86-78.92-93.53-2.11
Upgrade
Filing Date Shares Outstanding
60.7362.3563.3361.7456.33
Upgrade
Total Common Shares Outstanding
60.6362.2663.2161.6356.17
Upgrade
Working Capital
3,5901,8991,6731,8022,186
Upgrade
Book Value Per Share
67.5260.0348.8264.3465.15
Upgrade
Tangible Book Value
-2,378-3,434-4,401-5,015506.39
Upgrade
Tangible Book Value Per Share
-39.22-55.16-69.63-81.369.02
Upgrade
Land
71.970.9168.9464.0147.56
Upgrade
Machinery
116.14107.57100.4999.7363.81
Upgrade
Construction In Progress
34.4918.6667.3986.517.26
Upgrade
Leasehold Improvements
70.267.7264.7866.3254.11
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q